Back to search

Georgia Institute of Technology

Development of microneedle patches for measles-rubella vaccination and extended delivery vaccination

Abstract

dc:description.abstract

Despite cheap and effective vaccines, nearly 1.5 million children die each year from vaccine preventable diseases. The World Health Organization has called for novel vaccine technologies that can reduce needle-and-syringe use, reduce the dose of vaccine required, and reduce vaccine wastage, all while inducing an appropriate immune response. Microneedle patches offer a unique method of delivering vaccines into the skin without the use of needles and syringes. These patches consist of an array of needles in which each needle is composed of water-soluble polymers, sugars, excipients, and the vaccine. When inserted into the skin, the needles dissolve and deliver their embedded cargo. These patches meet a critical need for vaccination campaigns. They come in small, single dose packaging and can be administered by minimally trained personnel. Once dissolved, the needles leave no sharps waste. Additionally, the patches can be stored at elevated temperatures without damage to the vaccine. When the vaccine is delivered into the skin, studies have shown improved immune response compared to a standard intramuscular injection. This work developed two novel uses for microneedle patches. The first innovation delivers both measles and rubella vaccines in a single patch. Formulations were developed to minimize the loss of vaccine activity during the manufacturing process and subsequent storage at elevated temperatures. These patches were shown to be immunogenic in juvenile and infant rhesus macaques, and vaccination with a microneedle patch was able to protect the infants from a live measles viral challenge. The second project investigated a novel vaccination strategy using daily dosing to improve the immune response compared to a bolus injection. In this work, daily intradermal injections or daily microneedle patches were used to deliver vaccines over the course of one month, and this regime induced responses comparable to two bolus doses. The microneedle technologies developed in this work can improve vaccine coverage.

Degree

thesis:*
Level thesis:degree_level
Doctoral
Department dc:contributor.department
Biomedical Engineering (Joint GT/Emory Department)
Grantor dc:publisher
Georgia Institute of Technology
Year dc:date.issued
2017

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Joyce, Jessica Cheng
Advisor dc:contributor.advisor
  • Prausnitz, Mark R.
Committee members dc:contributor.committeemember
  • Roy, Krishnendu
  • Santangelo, Philip
  • Champion, Julie
  • Rota, Paul

Subjects

dc:subject × 11

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1853/60658

Chain of custody

source
Harvested from
Georgia Tech
Base URL
repository.gatech.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Joyce, Jessica Cheng. Development of microneedle patches for measles-rubella vaccination and extended delivery vaccination. Doctoral thesis, Georgia Institute of Technology, 2017. http://hdl.handle.net/1853/60658